Fiona T. Bane

508 total citations
11 papers, 311 citations indexed

About

Fiona T. Bane is a scholar working on Oncology, Molecular Biology and Genetics. According to data from OpenAlex, Fiona T. Bane has authored 11 papers receiving a total of 311 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Oncology, 6 papers in Molecular Biology and 6 papers in Genetics. Recurrent topics in Fiona T. Bane's work include Estrogen and related hormone effects (6 papers), HER2/EGFR in Cancer Research (3 papers) and Thyroid Cancer Diagnosis and Treatment (2 papers). Fiona T. Bane is often cited by papers focused on Estrogen and related hormone effects (6 papers), HER2/EGFR in Cancer Research (3 papers) and Thyroid Cancer Diagnosis and Treatment (2 papers). Fiona T. Bane collaborates with scholars based in Ireland, United States and United Kingdom. Fiona T. Bane's co-authors include Leonie S. Young, Arnold D. Hill, Marie McIlroy, Thomas B. Crotty, Damir Varešlija, Aisling M. Redmond, Mary F. Dillon, Sinéad Cocchiglia, Christopher Byrne and Jean McBryan and has published in prestigious journals such as Nature Communications, Cancer Research and Oncogene.

In The Last Decade

Fiona T. Bane

11 papers receiving 307 citations

Peers

Fiona T. Bane

GENET

ONCOL

PRM

Katia Bouchekioua‐Bouzaghou France

Stephen Johnston United Kingdom

Fransiscus E. Utama United States

Benjamin Sunkel United States

Jean‐Marc Rey France

Irene Recchia Italy

Christina K. Galang United States

Merja A. Helenius Finland

Huai-Chin Chiang United States

Jen‐Chine Wu Taiwan

Katia Bouchekioua‐Bouzaghou France

Fiona T. Bane

297 ×1.8

123 ×0.9

GENET

118 ×0.9

ONCOL

34 ×0.5

49 ×0.8

PRM

Citations per year, relative to Fiona T. Bane Fiona T. Bane (= 1×) peers Katia Bouchekioua‐Bouzaghou

Countries citing papers authored by Fiona T. Bane

Since Specialization

Citations

This map shows the geographic impact of Fiona T. Bane's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Fiona T. Bane with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Fiona T. Bane more than expected).

Fields of papers citing papers by Fiona T. Bane

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Fiona T. Bane. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Fiona T. Bane. The network helps show where Fiona T. Bane may publish in the future.

Co-authorship network of co-authors of Fiona T. Bane

This figure shows the co-authorship network connecting the top 25 collaborators of Fiona T. Bane. A scholar is included among the top collaborators of Fiona T. Bane based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Fiona T. Bane. Fiona T. Bane is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

11 of 11 papers shown

Daly, Gordon, Michael Flanagan, Mihaela Ola, et al.. (2024). Neoadjuvant HER2 inhibition induces ESR1 DNA methylation alterations resulting in clinically relevant ER expression changes in breast cancers. Cancer Communications. 45(2). 198–202. 1 indexed citations

Cosgrove, Nicola, Damir Varešlija, Stephen Keelan, et al.. (2022). Mapping molecular subtype specific alterations in breast cancer brain metastases identifies clinically relevant vulnerabilities. Nature Communications. 13(1). 514–514. 53 indexed citations

Creevey, Laura, Stephen F. Madden, Sinéad Toomey, et al.. (2019). Altered Steroid Milieu in AI-Resistant Breast Cancer Facilitates AR Mediated Gene-Expression Associated with Poor Response to Therapy. Molecular Cancer Therapeutics. 18(10). 1731–1743. 9 indexed citations

Charmsaz, Sara, Damir Varešlija, Ailís Fagan, et al.. (2018). Network analysis of SRC-1 reveals a novel transcription factor hub which regulates endocrine resistant breast cancer. Oncogene. 37(15). 2008–2021. 24 indexed citations

Charmsaz, Sara, Fiona T. Bane, Paul Tibbitts, et al.. (2017). S100β as a serum marker in endocrine resistant breast cancer. BMC Medicine. 15(1). 79–79. 19 indexed citations

McBryan, Jean, Ailís Fagan, Damian McCartan, et al.. (2015). Transcriptomic Profiling of Sequential Tumors from Breast Cancer Patients Provides a Global View of Metastatic Expression Changes Following Endocrine Therapy. Clinical Cancer Research. 21(23). 5371–5379. 20 indexed citations

Qin, Li, Michael J. Toneff, Dabing Li, et al.. (2014). NCOA1 Directly Targets M-CSF1 Expression to Promote Breast Cancer Metastasis. Cancer Research. 74(13). 3477–3488. 46 indexed citations

Varešlija, Damir, Jean McBryan, Fiona T. Bane, et al.. (2012). AIB1:ERα Transcriptional Activity Is Selectively Enhanced in Aromatase Inhibitor–Resistant Breast Cancer Cells. Clinical Cancer Research. 18(12). 3305–3315. 33 indexed citations

McIlroy, Marie, Eddie Myers, Fiona T. Bane, et al.. (2010). The role of oestrogen receptor α in human thyroid cancer: contributions from coregulatory proteins and the tyrosine kinase receptor HER2. Endocrine Related Cancer. 17(1). 255–264. 27 indexed citations

10.

Redmond, Aisling M., Fiona T. Bane, Marie McIlroy, et al.. (2009). Coassociation of Estrogen Receptor and p160 Proteins Predicts Resistance to Endocrine Treatment; SRC-1 is an Independent Predictor of Breast Cancer Recurrence. Clinical Cancer Research. 15(6). 2098–2106. 69 indexed citations

11.

Bane, Fiona T., Stephen R. Pennington, Giuseppe Campiani, et al.. (2009). The Microtubule-Targeting Agents, PBOX-6 [Pyrrolobenzoxazepine 7-[(dimethylcarbamoyl)oxy]-6-(2-naphthyl)pyrrolo-[2,1-d] (1,5)-benzoxazepine] and Paclitaxel, Induce Nucleocytoplasmic Redistribution of the Peptidyl-Prolyl Isomerases, Cyclophilin A and Pin1, in Malignant Hematopoietic Cells. Journal of Pharmacology and Experimental Therapeutics. 329(1). 38–47. 10 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact